|
Technical Information
The Arrow LionHeart™ Left Ventricular Assist System (LVAS),
manufactured by Arrow International, Inc., is a
"destination therapy" for patients with progressive,
irreversible, end stage (Class IV) congestive heart
failure. The Arrow LionHeart™ LVAS is not intended as a
bridge to transplant or as a bridge to recovery of
ventricular function. These patients are not eligible for
heart transplantation.
One feature that sets the Arrow LionHeart™ apart is its
fully implantable components that eliminate the need for
wires and tubes to come through the skin, as most of the
short term-Ventricular Assist Devices (VADs) do. An
internal battery pack is charged through the skin. The
absence of lines and wires through the skin is expected to
result in a lower risk of infection, improved mobility and
better quality of life.
|
